These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22433134)

  • 1. Extra-oesophageal reflux: state of the knowledge base.
    Ah-See K; Wilson J
    Clin Otolaryngol; 2012 Feb; 37(1):9-16. PubMed ID: 22433134
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Greenspan NR
    Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of reflux-related symptoms.
    Dutta U; Moayyedi P
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):387-400. PubMed ID: 23998977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastro-oesophageal reflux. Physiological or pathological?
    Marchetti F; Tornese G; Ventura A
    BMJ; 2010 Sep; 341():c5155. PubMed ID: 20861110
    [No Abstract]   [Full Text] [Related]  

  • 9. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GERD in 2010: diagnosis, novel mechanisms of disease and promising agents.
    Kandulski A; Malfertheiner P
    Nat Rev Gastroenterol Hepatol; 2011 Feb; 8(2):73-4. PubMed ID: 21293505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and treatment protocol for gastroesophageal reflux disease in children].
    ;
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):96. PubMed ID: 16624022
    [No Abstract]   [Full Text] [Related]  

  • 14. Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
    Galmiche JP
    Gut; 2006 Oct; 55(10):1379-81. PubMed ID: 16966695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Hershcovici T; Jha LK; Cui H; Powers J; Fass R
    Aliment Pharmacol Ther; 2011 Apr; 33(7):837-44. PubMed ID: 21261670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor influence on reflux in Barrett's oesophagus.
    Smythe A; Troy GP; Ackroyd R; Bird NC
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):881-7. PubMed ID: 18794602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Frazzoni M; Conigliaro R; Melotti G
    Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal Motility Disorders and Gastroesophageal Reflux Disease.
    Mittal R; Vaezi MF
    N Engl J Med; 2020 Nov; 383(20):1961-1972. PubMed ID: 33176086
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W; Vela MF; Castell DO
    J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux in patients with laryngeal disorders.
    Vanhemmens S; Wellens W; Tack J
    B-ENT; 2005; 1(3):117-23. PubMed ID: 16255496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.